Literature DB >> 25073670

A case of recurrent abdominal pain with fever and urticarial eruption.

Chang Geun Lee1, Yun Jeong Lim, Hyoun Woo Kang, Jae Hak Kim, Jun Kyu Lee, Moon Soo Koh, Jin Ho Lee, Hee Jin Huh, Seung Ho Lee.   

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by recurrent episodes of fever and serosal, synovial, or cutaneous inflammation, caused by a dysfunction of pyrin as a result of mutation within the MEFV gene. It occurs mainly among Mediterranean and Middle Eastern populations, including Jews, Arabs, and Turks. However, FMF cases have been reported outside the Mediterranean and Middle Eastern countries in recent years. Although FMF has been relatively rare in Korea until now, proper recognition of FMF might lead to more frequent diagnoses of FMF. We experienced an interesting case, a 31-year-old Korean man who presented with recurrent abdominal pain with fever and urticarial eruption for 10 years. DNA analysis showed complex mutations (p.Leu110Pro, p.Glu148Gln) in the MEFV gene. To date, three cases have been reported, and this case of FMF with skin conditions is the first case in Korea.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25073670     DOI: 10.4166/kjg.2014.64.1.40

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  3 in total

1.  Thiol/disulphide homeostasis in pregnant women with Familial Mediterranean fever.

Authors:  Aykan Yucel; Cem Yasar Sanhal; Korkut Daglar; Ozgur Kara; Dilek Uygur; Ozcan Erel
Journal:  Redox Rep       Date:  2016-03-31       Impact factor: 4.412

2.  Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy.

Authors:  Kwang Taek Kim; Hyun Joo Jang; Jae Eun Lee; Mi Kang Kim; Jun Jae Yoo; Gye Yeon Lee; Sea Hyub Kae; Jin Lee
Journal:  Intest Res       Date:  2015-06-09

3.  S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever.

Authors:  Ali Taylan; Oguz Gurler; Burak Toprak; Ali Riza Sisman; Hulya Yalcin; Ayfer Colak; Ismail Sari
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.